Efficacy and Safety of Add-on Treatment with Mirabegron for Benign Prostatic Hyperplasia Patients with Persistent Storage Symptoms after Alpha‌- blocker therapy.

Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study

Safety and Efficacy of Mirabegron in Treatment of Nocturnal Enuresis in Children

Safety and Efficacy of Holmium Laser Bladder Neck Incision for Small Prostate in Patients with and without Antithrombotic Therapy: A Prospective Study

Predicting the Outcome of Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia Treated with Alpha Blocker Monotherapy by Measurement of Bladder and Prost

Safety and Efficacy of Intermittent Versus Continuous Anticholinergic Medication in Management of Overactive Bladder in Adult

Prospective Comparative Study between Silodosin 8 mg Versus Combination of Tadalafil 5mg and Silodosin 4mgfor treatment of Lower Urinary Tract Symptoms related to Benign Prostati

Mirabegrone versus Solifenacine in Treatment of Overactive Bladder in Female Patients in Zagazig University Hospitals

Effect of Silodosin versus Tamsulosin in the Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: Review Article

Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study